샘플 요청 목록

 카트 문의
시장보고서
상품코드
2132487

의료용 로봇 시스템 시장 규모, 점유율, 동향 분석 보고서 : 종류별, 지역별 및 부문별 예측(2026-2033년)

Medical Robotic Systems Market Size, Share & Trends Analysis Report By Type (Surgical Robots, Exo-Robots, Cleanroom Robots, Exo-Robots, Pharma Robots, Medical Service Robots, Robotic Prosthetics), By Region, And Segment Forecasts, 2026 - 2033
발행일: | 리서치사: 구분자 Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.
US $ 5,950 금액 안내 화살표 ￦ 8,116,000
Printable PDF & Excel (5-User License) help
보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.
US $ 6,950 금액 안내 화살표 ￦ 9,480,000
Printable PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 8,950 금액 안내 화살표 ￦ 12,208,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

의료용 로봇 시스템 시장 요약

세계의 의료용 로봇 시스템 시장 규모는 2025년에 167억 달러로 평가되며, 2026년 203억 달러에서 2033년까지 551억 달러로 확대될 것으로 예상되며, 2026년부터 2033년까지 CAGR은 15.3%에 달할 것으로 예측됩니다.

북미가 시장을 주도하며, 2025년에는 매출 점유율의 46.6%를 차지했습니다. 이 업계는 최소침습 수술에 대한 수요 증가에 힘입어 성장하고 있습니다.

시장의 집중도와 특징

이 업계는 인공지능, 기계 학습, 고해상도 영상 기술의 발전에 힘입어 첨단 혁신이 특징입니다. 이러한 혁신을 통해 수술의 정밀도, 유연성, 제어성이 향상되어 환자의 치료 성과를 개선하는 최소침습 수술이 가능해졌습니다. 지속적인 연구 개발 노력을 통해 더욱 정교하고 사용자 친화적인 로봇 시스템이 개발되고 있으며, 다양한 외과 전문 분야로의 적용이 확대되면서 시장 성장을 뒷받침하고 있습니다. 예를 들어, 2026년 4월, 캘리포니아 대학교 샌디에이고 헬스(UC San Diego Health)는 AI, 3D 영상, 환자 맞춤형 임플란트, 내비게이션 및 로봇을 통한 나사 삽입 기능을 통합한 새로운 플랫폼을 사용하여 서부 해안에서 최초로 AI 로봇 척추 수술을 시행했습니다.

“이 플랫폼은 척추 수술에 대한 우리의 사고방식을 근본적으로 바꿔 놓을 것입니다. 인공지능, 데이터 기반의 정렬 계획, 환자별로 맞춤화된 임플란트, 내비게이션, 로봇을 이용한 나사 삽입을 처음으로 단일 시스템에 통합했습니다. 이러한 수준의 정밀도와 협업 덕분에 수술을 더 효율적으로 수행함과 동시에 환자의 안전성을 크게 향상시킬 수 있습니다.”

조셉 오소리오 의학박사(PhD), UC 샌디에이고 헬스 소속 신경외과 전문의

업계에서는 합병·인수(M&A) 활동이 활발해지고 있습니다. 대형 의료·기술 기업들은 제품 포트폴리오를 강화하고 첨단 기술을 활용하기 위해 소규모의 혁신적인 기업들을 인수하고 있습니다. 예를 들어, 2025년 7월, 지머 바이오메트는 모노그램 테크놀러지스를 약 1억 7,700만 달러에 인수하는 최종 합의를 발표했습니다. 이는 반자율형 및 완전 자율형 외과 수술 기술을 통해 로봇 기술 포트폴리오를 확대하고, AI를 활용한 정형외과용 로봇 분야에서의 입지를 강화하기 위한 것입니다.

규제는 안전성, 유효성, 품질을 확보함으로써 업계에 막대한 영향을 미치고 있습니다. FDA 등 규제 당국의 엄격한 승인 절차나 CE 마크 요건은 시장 진입을 지연시킬 가능성이 있지만, 동시에 신뢰성과 확실성을 구축하는 데에도 기여합니다. 이러한 규제를 준수하기 위해서는 연구 개발에 막대한 투자가 필요합니다. 그러나 규제 체계를 성공적으로 극복할 수 있다면 시장 내 신뢰도가 높아지고, 의료진의 도입이 촉진되어 궁극적으로 시장 성장을 견인하게 될 것입니다.

제품 라인업 확충에는 다양한 외과 전문 분야에 맞춘 새롭고 첨단적인 로봇 솔루션의 도입이 포함됩니다. 예를 들어, 2026년 4월, SS Innovations는 SMRSC 2026에서 SSi Vimana Aero 드론 시스템과 SSi Avtara 휴머노이드 플랫폼을 포함한 차세대 수술용 로봇 기술을 발표하며, 원격 수술, 전장 의료 및 이동형 로봇 수술 환경에서의 진전을 강조했습니다.

“혁신은 우리 회사의 DNA에 깊이 새겨져 있습니다. 첨단이며 비용 효율적인 SSi Mantra 수술용 로봇 시스템과 원격 수술 기능의 지속적인 개선에 그치지 않고, 지원이 필요한 더 폭넓은 환자층의 의료 수준을 획기적으로 향상시킬 새로운 수술용 로봇 기술 개척에도 전력을 다하고 있습니다. 당사 역사상 최대 규모로 열린 SMRSC 2026에서 이 중요한 주제를 성공적으로 선보일 수 있었습니다.”

SS Innovations 이사회 의장 겸 최고경영자(CEO) 수디르 스리바스타바 박사

전 세계적인 사업 확장은 신흥 경제국에서의 도입 증가, 의료 인프라 개선, 그리고 지원적인 정부 정책에 의해 추진되고 있습니다. 각 기업은 아시아태평양, 라틴아메리카, 중동 등의 지역을 타겟으로, 현지 파트너십과 투자를 활용하여 증가하는 수요를 흡수하고 국제 시장에서의 입지를 강화하고 있습니다. 예를 들어, 2026년 1월, 아메리칸 호스피탈 두바이는 ‘다빈치 5(da Vinci 5)’ 로봇 수술 시스템을 도입했습니다. 이는 해당 지역 최초의 도입 사례로, 첨단 로봇 수술 역량을 확충함으로써 수술 정밀도 향상, 조직 처리 개선, 그리고 최소침습 수술의 추가적인 보급을 가능하게 했습니다.

자주 묻는 질문

  • 의료용 로봇 시스템 시장 규모는 어떻게 예측되나요?
  • 의료용 로봇 시스템 시장에서 북미의 점유율은 어떻게 되나요?
  • 의료용 로봇 시스템 시장의 주요 혁신 기술은 무엇인가요?
  • 의료용 로봇 시스템 시장에서 활발한 M&A 활동의 이유는 무엇인가요?
  • 의료용 로봇 시스템의 규제는 시장에 어떤 영향을 미치나요?
  • 의료용 로봇 시스템의 제품 라인업 확충은 어떤 방향으로 진행되고 있나요?
  • 의료용 로봇 시스템 시장의 글로벌 사업 확장은 어떤 요인에 의해 추진되나요?

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 의료용 로봇 시스템 시장 : 변수, 동향, 범위

제4장 의료용 로봇 시스템 시장 : 유형별 추정·동향 분석

제5장 의료용 로봇 시스템 시장 : 지역별 추정·동향 분석

제6장 경쟁 구도

KSM 26.09.28

Medical Robotic Systems Market Summary

The global medical robotic systems market size was valued at USD 16.7 billion in 2025 and is projected to grow from USD 20.3 billion in 2026 to USD 55.1 billion by 2033, at a CAGR of 15.3% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 46.6% in 2025. The industry is driven by the rising preference for minimally invasive procedures.

Market Concentration & Characteristics

The industry is marked by a high degree of innovation, driven by advancements in artificial intelligence, machine learning, and high-definition imaging technologies. These innovations enhance surgical precision, flexibility, and control, allowing for minimally invasive procedures with improved patient outcomes. Continuous research and development efforts are leading to more sophisticated, user-friendly robotic systems, expanding their application across various surgical specialties and boosting market growth. For instance, in April 2026, UC San Diego Health performed the West Coast's first AI robotic spine surgery using a new platform integrating AI, 3D imaging, patient-specific implants, navigation, and robotic screw delivery.

"This platform fundamentally changes how we think about spine surgery. For the first time, we are bringing together artificial intelligence, data-driven alignment planning, patient-specific implants, navigation, and robotic screw delivery within a single system. That level of precision and coordination allows us to operate more efficiently while significantly enhancing safety for our patients."

Joseph Osorio, MD, PhD, neurosurgeon at UC San Diego Health

The industry is witnessing a high level of mergers and acquisitions (M&A) activity. Major healthcare and technology companies are acquiring smaller, innovative firms to enhance their product portfolios and leverage advanced technologies. For instance, in July 2025, Zimmer Biomet announced a definitive agreement to acquire Monogram Technologies for approximately USD 177 million, aiming to expand its robotics portfolio with semi- and fully autonomous surgical technologies and strengthen its position in AI-enabled orthopedic robotics.

Regulations significantly impact the industry by ensuring safety, efficacy, and quality. Stringent approval processes by regulatory bodies such as the FDA and CE mark requirements can delay market entry, but also build trust and reliability. Compliance with these regulations demands substantial investment in research and development. However, successful navigation of regulatory frameworks enhances market credibility, encourages adoption by healthcare providers, and ultimately drives market growth.

Product expansion involves introducing new and advanced robotic solutions tailored to various surgical specialties. For instance, in April 2026, SS Innovations launched next-generation surgical robotic technologies, including the SSi Vimana Aero drone system and SSi Avtara humanoid platform, highlighting advancements in remote surgery, battlefield care, and mobile robotic operating environments at SMRSC 2026.

"Innovation is in our DNA. Beyond continuously improving our advanced, cost-effective SSi Mantra surgical robotic system and telesurgery capabilities, we strive to pioneer new surgical robotic technologies that will meaningfully improve healthcare for a wider segment of patients in need. SMRSC 2026, our largest conference yet, successfully elevated this important theme."

Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations

Global expansion is driven by increasing adoption in emerging economies, improved healthcare infrastructure, and supportive government policies. Companies are targeting regions like Asia-Pacific, Latin America, and the Middle East, leveraging local partnerships and investments to tap into growing demand and enhance their international market presence. For instance, in January 2026, American Hospital Dubai deployed the da Vinci 5 robotic surgical system, marking the region's first installation and expanding advanced robotic surgery capabilities, enabling enhanced surgical precision, improved tissue handling, and broader adoption of minimally invasive procedures.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
  • 1.3. Regional Scope
  • 1.4. Estimates and forecasts timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased database
    • 1.6.2. GVR's internal database
    • 1.6.3. Secondary sources
    • 1.6.4. Primary research
    • 1.6.5. Details of primary research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data analysis models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity flow analysis (Model 1)
    • 1.9.2. Approach 1: Commodity flow approach
    • 1.9.3. Volume price analysis (Model 2)
    • 1.9.4. Approach 2: Volume price analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Primary Sources
  • 1.12. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Medical Robotic Systems Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Medical Robotic Systems Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Medical Robotic Systems Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Medical Robotic Systems Market: Type Movement Analysis
  • 4.3. Medical Robotic Systems Market by Type Outlook (USD Billion)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Surgical Robots
    • 4.5.1. Surgical Robots Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.5.2. General Surgery
      • 4.5.2.1. General Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.5.3. Gynecology
      • 4.5.3.1. Gynecology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.5.4. Urology
      • 4.5.4.1. Urology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.5.5. Orthopedic Surgery
      • 4.5.5.1. Orthopedic Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.5.6. Neurosurgery
      • 4.5.6.1. Neurosurgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.5.7. Cardiac Surgery
      • 4.5.7.1. Cardiac Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.5.8. Bariatric
      • 4.5.8.1. Bariatric Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.5.9. Bronchoscopy/Pulmonary
      • 4.5.9.1. Bronchoscopy/Pulmonary Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.5.10. Others
      • 4.5.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.6. Exo-Robots
    • 4.6.1. Exo-Robots Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.6.2. Upper Body
      • 4.6.2.1. Upper Body Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.6.3. Lower Body
      • 4.6.3.1. Lower Body Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.6.4. Full Body
      • 4.6.4.1. Full Body Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.7. Pharma Robots
    • 4.7.1. Pharma Robots Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.7.2. Traditional Robots
      • 4.7.2.1. Traditional Robots Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
      • 4.7.2.2. Articulated Robots
        • 4.7.2.2.1. Articulated Robots Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
      • 4.7.2.3. Delta/Parallel Robots
        • 4.7.2.3.1. Delta/Parallel Robots Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
      • 4.7.2.4. SCARA Robots
        • 4.7.2.4.1. SCARA Robots Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
      • 4.7.2.5. Dual-Arm Robots
        • 4.7.2.5.1. Dual-Arm Robots Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
      • 4.7.2.6. Cartesian Robots
        • 4.7.2.6.1. Cartesian Robots Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.7.3. Collaborative Robots
      • 4.7.3.1. Collaborative Robots Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.8. Medical Service Robots
    • 4.8.1. Medical Service Robots Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.8.2. Dispensing Robots
      • 4.8.2.1. Dispensing Robots Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.8.3. Disinfection Robots
      • 4.8.3.1. Disinfection Robots Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.8.4. Delivery Robots
      • 4.8.4.1. Delivery Robots Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.8.5. Medical Telepresence Robots
      • 4.8.5.1. Medical Telepresence Robots Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.8.6. Robotic nurse assistants
      • 4.8.6.1. Robotic Nurse Assistants Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.8.7. Others
      • 4.8.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.9. Cleanroom Robots
    • 4.9.1. Cleanroom Robots Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.9.2. Traditional Robots
      • 4.9.2.1. Traditional Robots Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
      • 4.9.2.2. Articulated Robots
        • 4.9.2.2.1. Articulated Robots Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
      • 4.9.2.3. Parallel Robots
        • 4.9.2.3.1. Parallel Robots Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
      • 4.9.2.4. SCARA Robots
        • 4.9.2.4.1. SCARA Robots Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
      • 4.9.2.5. Cartesian Robots
        • 4.9.2.5.1. Cartesian Robots Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.9.3. Collaborative Robots
      • 4.9.3.1. Collaborative Robots Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Medical Robotic Systems Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Dashboard
  • 5.2. Regional Medical Robotic Systems Market movement analysis
  • 5.3. Medical Robotic Systems Market: Regional Estimates & Trend Analysis by Type
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. North America
    • 5.5.1. North America Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. U.S.
      • 5.5.2.1. U.S. Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.3. Canada
      • 5.5.3.1. Canada Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.4. Mexico
      • 5.5.4.1. Mexico Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.5. Europe
    • 5.5.6. Europe Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.7. UK
      • 5.5.7.1. UK Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.8. Germany
      • 5.5.8.1. Germany Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.9. France
      • 5.5.9.1. France Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.10. Italy
      • 5.5.10.1. Italy Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.11. Spain
      • 5.5.11.1. Spain Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.12. Denmark
      • 5.5.12.1. Denmark Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.13. Norway
      • 5.5.13.1. Norway Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.14. Sweden
      • 5.5.14.1. Sweden Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. Asia Pacific Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.2. Japan
      • 5.6.2.1. Japan Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.3. China
      • 5.6.3.1. China Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.4. India
      • 5.6.4.1. India Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.5. South Korea
      • 5.6.5.1. South Korea Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.6. Australia
      • 5.6.6.1. Australia Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.7. Thailand
      • 5.6.7.1. Thailand Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Latin America Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.2. Brazil
      • 5.7.2.1. Brazil Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.3. Argentina
      • 5.7.3.1. Argentina Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Middle East & Africa
    • 5.8.1. Middle East & Africa Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.8.2. South Africa
      • 5.8.2.1. South Africa Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.8.3. Saudi Arabia
      • 5.8.3.1. Saudi Arabia Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.8.4. UAE
      • 5.8.4.1. UAE Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.8.5. Kuwait
      • 5.8.5.1. Kuwait Medical Robotic Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Market Participant Categorization
  • 6.2. Key Company Profiles
    • 6.2.1. Intuitive Surgical
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Medtronic
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Stryker
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Zimmer Biomet
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Smith & Nephew
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Johnson & Johnson
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Siemens Healthineers
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. ABB
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Kawasaki Heavy Industries Ltd.
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. Yaskawa Electric Corporation
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives
    • 6.2.11. FANUC America Corporation
      • 6.2.11.1. Company overview
      • 6.2.11.2. Financial performance
      • 6.2.11.3. Product benchmarking
      • 6.2.11.4. Strategic initiatives
    • 6.2.12. Denso Corporation
      • 6.2.12.1. Company overview
      • 6.2.12.2. Financial performance
      • 6.2.12.3. Product benchmarking
      • 6.2.12.4. Strategic initiatives
    • 6.2.13. Ekso Bionics
      • 6.2.13.1. Company overview
      • 6.2.13.2. Financial performance
      • 6.2.13.3. Product benchmarking
      • 6.2.13.4. Strategic initiatives
    • 6.2.14. CMR Surgical
      • 6.2.14.1. Company overview
      • 6.2.14.2. Financial performance
      • 6.2.14.3. Product benchmarking
      • 6.2.14.4. Strategic initiatives
    • 6.2.15. Asensus Surgical
      • 6.2.15.1. Company overview
      • 6.2.15.2. Financial performance
      • 6.2.15.3. Product benchmarking
      • 6.2.15.4. Strategic initiatives
    • 6.2.16. Distalmotion
      • 6.2.16.1. Company overview
      • 6.2.16.2. Financial performance
      • 6.2.16.3. Product benchmarking
      • 6.2.16.4. Strategic initiatives
    • 6.2.17. Vicarious Surgical
      • 6.2.17.1. Company overview
      • 6.2.17.2. Financial performance
      • 6.2.17.3. Product benchmarking
      • 6.2.17.4. Strategic initiatives
    • 6.2.18. Wearable Robotics
      • 6.2.18.1. Company overview
      • 6.2.18.2. Financial performance
      • 6.2.18.3. Product benchmarking
      • 6.2.18.4. Strategic initiatives
    • 6.2.19. Rehab-Robotics Company Limited
      • 6.2.19.1. Company overview
      • 6.2.19.2. Financial performance
      • 6.2.19.3. Product benchmarking
      • 6.2.19.4. Strategic initiatives
    • 6.2.20. ExoAtlet
      • 6.2.20.1. Company overview
      • 6.2.20.2. Financial performance
      • 6.2.20.3. Product benchmarking
      • 6.2.20.4. Strategic initiatives
    • 6.2.21. MARSI BIONICS, S.L
      • 6.2.21.1. Company overview
      • 6.2.21.2. Financial performance
      • 6.2.21.3. Product benchmarking
      • 6.2.21.4. Strategic initiatives
    • 6.2.22. ABLE Human Motion
      • 6.2.22.1. Company overview
      • 6.2.22.2. Financial performance
      • 6.2.22.3. Product benchmarking
      • 6.2.22.4. Strategic initiatives
    • 6.2.23. Bioservo
      • 6.2.23.1. Company overview
      • 6.2.23.2. Financial performance
      • 6.2.23.3. Product benchmarking
      • 6.2.23.4. Strategic initiatives
    • 6.2.24. Wandercraft
      • 6.2.24.1. Company overview
      • 6.2.24.2. Financial performance
      • 6.2.24.3. Product benchmarking
      • 6.2.24.4. Strategic initiatives
    • 6.2.25. autonomyo
      • 6.2.25.1. Company overview
      • 6.2.25.2. Financial performance
      • 6.2.25.3. Product benchmarking
      • 6.2.25.4. Strategic initiatives
    • 6.2.26. INNOPHYS CO.,LTD.
      • 6.2.26.1. Company overview
      • 6.2.26.2. Financial performance
      • 6.2.26.3. Product benchmarking
      • 6.2.26.4. Strategic initiatives
    • 6.2.27. Universal Robots A/S
      • 6.2.27.1. Company overview
      • 6.2.27.2. Financial performance
      • 6.2.27.3. Product benchmarking
      • 6.2.27.4. Strategic initiatives
    • 6.2.28. Omnicell, Inc.
      • 6.2.28.1. Company overview
      • 6.2.28.2. Financial performance
      • 6.2.28.3. Product benchmarking
      • 6.2.28.4. Strategic initiatives
    • 6.2.29. Aethon, Inc.
      • 6.2.29.1. Company overview
      • 6.2.29.2. Financial performance
      • 6.2.29.3. Product benchmarking
      • 6.2.29.4. Strategic initiatives
    • 6.2.30. Diligent Robotics (Serve Robotics)
      • 6.2.30.1. Company overview
      • 6.2.30.2. Financial performance
      • 6.2.30.3. Product benchmarking
      • 6.2.30.4. Strategic initiatives
    • 6.2.31. UVD Robots
      • 6.2.31.1. Company overview
      • 6.2.31.2. Financial performance
      • 6.2.31.3. Product benchmarking
      • 6.2.31.4. Strategic initiatives
    • 6.2.32. Hstar Technologies
      • 6.2.32.1. Company overview
      • 6.2.32.2. Financial performance
      • 6.2.32.3. Product benchmarking
      • 6.2.32.4. Strategic initiatives
×

원하시는 정보를 찾아 드릴까요?

보안문자 새로고침
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기